Several media outlets have recently reported that the anticoagulant Eliquis (apixaban) will no longer be available to patients. This is incorrect.
We understand these reports may cause concern among patients and healthcare providers, and we would like to clarify the situation.
No shortage
It is important to emphasize that there is sufficient stock. Eliquis is available through multiple wholesalers and pharmacies.
Eliquis remains available
Bristol Myers Squibb delivers all orders in full to wholesalers who order from us.
We are aware that one wholesaler (Mosadex) is currently not supplying Eliquis to the pharmacies that would normally order from them due to a commercial dispute over purchasing conditions. This is unrelated to the medicine's availability or price. Other wholesalers continue to supply Eliquis to pharmacies as usual.
No need to switch
As there is sufficient stock, there is no reason for patients to switch to another medicine.
Advice to patients
Patients are free to choose their pharmacy. Patients are entitled to Eliquis through their health insurance and can continue to obtain Eliquis from their pharmacy or, if necessary, from another pharmacy in the area.
If you have any questions, we advise patients to contact their own pharmacy, health insurer, or treating physician.
